The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis

International Forum of Allergy and Rhinology

Volumn 1, Issue 6, 2011, Pages 438-444

  Jardeleza, Camille ^a   Foreman, Andrew ^a   Baker, Leonie ^a   Paramasivan, Sathish ^a   Field, John ^a   Tan, Lor Wai ^a   Wormald, Peter John ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Biofilms; Chronic rhinosinusitis; Comstat 2; Confocal; CRS; MBEC device; Nitric oxide; Staphylococcus aureus

Indexed keywords

NITRIC OXIDE;

ARTICLE; BACTERIUM ISOLATE; BIOFILM; BIOMASS; CHRONIC RHINOSINUSITIS; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; NONHUMAN; PARANASAL SINUS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

BIOFILMS; CHRONIC DISEASE; HUMANS; NITRIC OXIDE; RHINITIS; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84861380355     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.20083     Document Type: Article

References (30)

1. Davidson S, Koropatnick T, Kossmehl R, et al. NO means 'yes' in the squid-Vibrio symbiosis: nitric oxide (NO) during the initial stages of a beneficial association. Cell Microbiol. 2004;6:1139-1151.
2. Runer T, Cervin A, Lindberg S, et al. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg. 1998;119:278-287.
3. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic rhinosinusitis. Acta Otolaryngol. 1997;117:113-117.
4. Foreman A, Psaltis A, Tan LW, et al. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol. 2009;23:556-561.
5. Jervis-Bardy J, Foreman A, Field J, et al. Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery. Am J Rhinol Allergy. 2009;23:549-552.
6. Foreman A, Wormald PJ. Different biofilms, different disease? A clinical outcomes study. Laryngoscope. 2010;120:1701-1706.
7. Miller C, McMullin B, Ghaffari A, et al. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric Oxide. 2009;20:16-23.
8. Ghaffari A, Miller C, McMullin B, et al. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide. 2006;14:21-29.
9. Post JC, Stoodley P, Hall-Stoodley L, et al. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg. 2004;12:185-190.
10. Hunsaker D, Leid J. The relationship of biofilms to chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2008;16:237-241.
11. Lundberg JOM, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995;1:370-373.
12. Lundberg J. Nitric oxide and the paranasal sinuses. Anat Rec (Hoboken). 2008;291:1479-1484.
13. Degamo B, Genestal M, Serrano E, et al. Effect of treatment on maxillary sinus and nasal nitric oxide concentrations in patients with nosocomial maxillary sinusitis. Chest. 2005;128:1699-1705.
14. Deja M, Busch T, Bachmann S, et al. Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis. Am J Respir Crit Care Med. 2003;168:281-286.
15. Chaturvedi R, Asim M, Lewis N, et al. L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun. 2007;75:4305-4315.
16. Zhu Y, Weiss E, Otto M, et al. Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesion synthesis, biofilm formation and pathogenesis. Infect Immun. 2007;75:4219-4226.
17. - Pseudomonas fluorescens biofilms using representative elements. Biofouling. 1993;7:339-358.
18. Harrison J, Ceri H, Yerly J, et al. The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the Calgary Biofilm Device. Biol Proced Online. 2006;8:194-215.
19. Psaltis A, Ha K, Beule A, et al. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope. 2007;117:1302-1306.
20. Heydorn A, Nielsen A, Hentzer M, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology. 2000;146:2395-2407.
21. Heydorn A, Ersbøl B, Hentzer M, et al. Experimental reproducibility in flow-chamber biofilms. Microbiology. 2000;146:2409-2415.
22. Lundberg J, Weitzberg E, Gladwin M. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nature. 2008;7:156-166.
23. Jorissen M, Lefevere L, Williams T. Nasal nitric oxide. Allergy. 2001;56:1026-1033.
24. Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways inflammatory disease. Inflamm Res. 2007;56:58-59.
25. Barraud N, Hasset D, Hwang SH, et al. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol. 2006;188:7344-7353.
26. Schlag S, Nerz C, Birkenstock T, et al. Inhibition of Staphylococcal biofilm formation by nitrite. J Bacteriol. 2007;189:7911-7919.
27. Gusarov I, Shatalin K, Starodubtseva M, et al. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science. 2009;325:380-384.
28. Richardson A, Dunman P, Fang F. The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Mol Microbiol. 2006;61:927-939.
29. Kirihene R, Rees G, Wormald PJ. The influence of the size of the maxillary sinus ostium on the nasal and sinus nitric oxide levels. Am J Rhinol. 2002;16:261-264.
30. Rajab S, Lund V, Saleh H, et al. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy. 2006;61:717-724.